The APOC3 SstI polymorphism is weakly associated with sporadic Alzheimer's disease in a Chinese population

Neuroscience Letters

Volumn 380, Issue 3, 2005, Pages 219-222

  Sun, Yan ^a   Shi, Jiajun ^b   Zhang, Sizhong ^a   Tang, Mouni ^b   Han, Haiying ^b   Guo, Yangbo ^b   Ma, Cui ^b   Liu, Xiehe ^a   Li, Tao ^a  

^a SICHUAN UNIVERSITY   (China)

^b Guangzhou Psychiatry Hospital   (China)

Author keywords

Alzheimer's disease; Apolipoprotein CIII; Apolipoprotein E; Restriction fragment length polymorphism

Indexed keywords

APOLIPOPROTEIN C3; APOLIPOPROTEIN E;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CHINESE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION GENETICS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 18144416598     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2005.01.038     Document Type: Article

References (25)

1. K. Aalto-Setala, E.A. Fisher, X. Chen, T. Chajek-Shaul, T. Hayek, R. Zechner, A. Walsh, R. Ramakrishnan, H.N. Ginsberg, and J.L. Breslow Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apoCIII and reduced apo E on the particles J. Clin. Invest. 90 1992 1889 1900
2. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, fourth ed., American Psychiatric Association, Washington, DC, 1994.
3. D. Blacker, and R.E. Tanzi The genetics of Alzheimer disease: current status and future prospects Arch. Neurol. 55 1998 294 296
4. G.M. Dallinga-Thie, T.M. van Linde-Sibenius, J.I. Rotter, R.M. Cantor, X.D. Bu, A.J. Lusis, and T.W.A. de Bruin Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes J. Clin. Invest. 99 1997 953 961
5. M. Dammerman, L.A. Sandkuijl, J.L. Halaas, W. Chung, and J.L. Breslow An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 39 untranslated region polymorphisms Proc. Natl. Acad. Sci. U.S.A. 90 1993 4562 4566
6. H. Esterbauer, E. Hell, F. Krimpler, and P. Wolfgang Allele specific differences in apolipoprotein CIII mRNA expression in human liver Clin. Chem. 45 1999 331 339
7. M.F. Folstein, L.N. Robins, and J.E. Helzer The mini-mental state examination Arch. Gen. Psych. 40 1983 812
8. J.N. Hirschhorn, K. Lohmueller, E. Byrne, and K. Hirschhorn A comprehensive review of genetic association studies Genet. Med. 4 2002 45 61
9. J.E. Hixson, and D.T. Vernier Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI J. Lipid Res. 31 1990 545 548
10. J.E. Hixson, D.T. Vernier, and P.K. Powers Detection of SstI restriction site polymorphism in human APOC3 by the polymerase chain reaction Nucl. Acids Res. 19 1991 196
11. H. Houlden, R. Crook, K. Duff, M. Hutton, J. Collinge, P. Roques, M. Rossor, and J. Hardy Apolipoprotein E alleles but neither apolipoprotein B nor apolipoprotein AI/CIII alleles are associated with late onset, familial Alzheimer's disease Neurosci. Lett. 188 1995 202 204
12. M.C. Jong, M.H. Hofker, and L.M. Havekes Role of ApoCs in lipoprotein metabolism functional differences between ApoC1, ApoC2, and ApoC3 Arterioscler. Thromb. Vasc. Biol. 19 1999 472 484
13. S.K. Karanthansis Apolipoprotein multigene family: tandem organization of human apolipoprotein AI, CIII and AIV genes Proc. Natl. Acad. Sci. U.S.A. 82 1985 6374 6378
14. L.J. Launer, W. Ross, H. Petrovitch, K. Masaki, D. Foley, L.R. White, and R. Havlik Mid life blood pressure and dementia: the Honolulu-Asia Aging Study Neurobiol. Aging 21 2000 49 55
15. W.W. Li, M. Dammerman, J.D. Smith, S. Metzger, J.L. Breslow, and T. Leff Common genetic variation in the promoter of the human apoCIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia J. Clin. Invest. 96 1995 1601 1605
16. G.M. Mckhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCD-ADRDA work group under the auspices of the Department of Health and Human Services Task Forces on Alzheimer's disease Neurology 34 1984 939 944
17. P. Nowotny, J.M. Kwon, S. Chakraverty, V. Nowotny, J.C. Morris, and A.M. Goate Association studies using novel polymorphisms in BACE1 and BACE2 NeuroReport 9 2001 1799 1802
18. O. Olivieri, C. Stranieri, A. Bassi, B. Zaia, D. Girelli, F. Pizzolo, E. Trabetti, S. Cheng, M.A. Grow, P.F. Pignatti, and R. Corrocher ApoC-III gene polymorphisms and risk of coronary artery disease J. Lipid Res. 43 2002 1450 1457
19. F. Panza, A. D'Introno, A.M. Colacicco, A.M. Basile, C. Capurso, P.G. Kehoe, A. Capurso, and V. Solfrizzi Vascular risk and genetics of sporadic late-onset Alzheimer's disease J. Neural Transm. 111 2004 69 89
20. G.C. Roman, T.K. Tatemichi, T. Erkinjuntti, J.L. Cummings, J.C. Masdeu, J.H. Garcia, L. Amaducci, J.M. Orgogozo, A. Brun, and A. Hofman Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop Neurology 43 1993 250 260
21. G.T. Russo, J.B. Meigs, L.A. Cupples, S. Demissie, J.D. Otvos, P.W. Wilson, C. Lahoz, D. Cucinotta, P. Couture, T. Mallory, E.J. Schaefer, and J.M. Ordovas Association of the SstI polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study Atherosclerosis 158 2001 173 181
22. C.C. Shoulders, P.J. Harry, L. Lagrost, S.E. White, N.F. Shah, J.D. North, M. Gilligan, P. Gambert, and M.J. Ball Variation at the apo AI/CIII/AIVgene complex is associated with elevated plasma levels of apoCIII Atherosclerosis 87 1991 239 247
23. M. Simons, P. Keller, J. Dichgans, and J.B. Schulz Cholesterol and Alzheimer's disease: is there a link? Neurology 57 2001 1089 1093
24. M.S. Tsai, E.G. Tangalos, R.C. Petersen, G.E. Smith, D.J. Schaid, E. Kokmen, R.J. Ivnik, and S.N. Thibodeau Apolipoprotein E: risk factor for Alzheimer disease Am. J. Hum. Genet. 54 1994 643 649
25. T. Yoshizawa, K. Yamakawa-Kobayashi, Y. Komatsuzaki, T. Arinami, E. Oguni, H. Mizusawa, S. Shoji, and H. Hamaguchi Dose-dependent association of apolipoprotein E allele epsilon-4 with late-onset, sporadic Alzheimer's disease Ann. Neurol. 36 1994 656 659